Published in HPB (Oxford) on January 01, 2005
Association between hepatitis C and hepatocellular carcinoma. J Glob Infect Dis (2009) 1.15
Elevated plasma gamma-tocopherol and decreased alpha-tocopherol in men are associated with inflammatory markers and decreased plasma 25-OH vitamin D. Nutr Cancer (2008) 1.03
Aurora kinase inhibitor PHA-739358 suppresses growth of hepatocellular carcinoma in vitro and in a xenograft mouse model. Neoplasia (2009) 0.98
Development of a new orthotopic animal model of metastatic liver cancer in the rabbit VX2 model: effect on metastases after partial hepatectomy, intra-arterial treatment with 3-bromopyruvate and chemoembolization. Clin Exp Metastasis (2008) 0.88
Musashi-2 promotes hepatitis Bvirus related hepatocellular carcinoma progression via the Wnt/β-catenin pathway. Am J Cancer Res (2015) 0.84
Situs Inversus Totalis (SIT) with Hepatocellular Carcinoma (HCC): A Rare Case Report and Review of 12 Other Cases. Indian J Surg (2012) 0.83
High risk of primary liver cancer in a cohort of 179 patients with Acute Hepatic Porphyria. J Inherit Metab Dis (2013) 0.83
Percutaneous Irreversible Electroporation: Long-term survival analysis of 71 patients with inoperable malignant hepatic tumors. Sci Rep (2017) 0.78
Resection or transplant-listing for solitary hepatitis C-associated hepatocellular carcinoma: an intention-to-treat analysis. HPB (Oxford) (2012) 0.77
Abrus agglutinin suppresses human hepatocellular carcinoma in vitro and in vivo by inducing caspase-mediated cell death. Acta Pharmacol Sin (2014) 0.77
The transcriptomic G1-G6 signature of hepatocellular carcinoma in an Asian population: Association of G3 with microvascular invasion. Medicine (Baltimore) (2016) 0.75
Colors of vegetables and fruits and the risks of colorectal cancer. World J Gastroenterol (2017) 0.75
Hypermethylation reduces the expression of PNPLA7 in hepatocellular carcinoma. Oncol Lett (2016) 0.75
The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update. Ann Intern Med (2003) 6.06
Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa. Nature (1991) 6.04
HBx gene of hepatitis B virus induces liver cancer in transgenic mice. Nature (1991) 5.34
Hepatocellular carcinoma: an epidemiologic view. J Clin Gastroenterol (2002) 3.83
Survival and causes of death in cirrhotic and in noncirrhotic patients with primary hemochromatosis. N Engl J Med (1985) 3.73
Alpha 1-antitrypsin deficiency, emphysema, and liver disease. Genetic basis and strategies for therapy. J Clin Invest (1990) 2.35
Hepatitis C-related hepatocellular carcinoma in the United States: influence of ethnic status. Am J Gastroenterol (2003) 2.18
Hepatocellular carcinoma. A worldwide problem and the major risk factors. Dig Dis Sci (1991) 2.12
The occurrence of hepatoma in the chronic form of hereditary tyrosinemia. J Pediatr (1976) 2.04
Epidemiology of hepatocellular carcinoma. Can J Gastroenterol (2000) 1.80
Malignant transformation of adenomatous hyperplasia to hepatocellular carcinoma. Lancet (1990) 1.75
Nodular transformation (nodular "regenerative" hyperplasia) of the liver. A clinicopathologic study of 30 cases. Hum Pathol (1981) 1.73
Morphologic studies of the liver cell dysplasia. Cancer (1983) 1.70
Establishment of methylation-sensitive-representational difference analysis and isolation of hypo- and hypermethylated genomic fragments in mouse liver tumors. Proc Natl Acad Sci U S A (1997) 1.48
Primary hepatic tumors of childhood. Hum Pathol (1983) 1.48
Cellular adaptation in the origin and development of cancer. Cancer Res (1991) 1.47
Hepatocarcinogenesis. Trop Gastroenterol (1990) 1.44
Diet and cancer--an overview. N Engl J Med (1984) 1.43
Primary prevention of hepatocellular carcinoma. J Gastroenterol Hepatol (1996) 1.40
Hepatocellular carcinoma in woodchuck hepatitis virus-infected woodchucks: presence of viral DNA in tumor tissue from chronic carriers and animals serologically recovered from acute infections. Hepatology (1989) 1.39
Increasing incidence of hepatocellular carcinoma possibly associated with non-A, non-B hepatitis in Japan, disclosed by hepatitis B virus DNA analysis of surgically resected cases. Cancer Res (1988) 1.36
Complex segregation analysis of primary hepatocellular carcinoma in Chinese families: interaction of inherited susceptibility and hepatitis B viral infection. Am J Hum Genet (1991) 1.30
Cirrhosis and hepatoma occurring at Boston City Hospital (1917-1968). Cancer (1973) 1.26
Membranous obstruction of the inferior vena cava and hepatocellular carcinoma in South Africa. Gastroenterology (1982) 1.25
p53 mutations cluster at codon 249 in hepatitis B virus-positive hepatocellular carcinomas from China. Cancer Res (1992) 1.23
Hepatitis B virus infection in Asian Americans. Gastroenterol Clin North Am (1994) 1.16
Epidemiology of hepatocellular carcinoma. Gastroenterol Clin North Am (1987) 1.12
The risk of end stage liver disease and hepatocellular carcinoma among persons infected with hepatitis C virus: publication bias? Am J Gastroenterol (2003) 1.12
Glycogen storage disease I and hepatocellular tumours. Eur J Pediatr (1993) 1.10
Hepatocellular carcinoma in a noncirrhotic infant after prolonged parenteral nutrition. J Pediatr (1985) 1.10
Liver pathology associated with the use of anabolic-androgenic steroids. Liver (1992) 1.09
Hepatitis B virus HBx gene and hepatocarcinogenesis. Intervirology (1995) 1.06
Growth factors, endocrine aspects and hormonal treatment in hepatocellular carcinoma--an overview. J Steroid Biochem Mol Biol (1990) 1.03
DNA methylation and hepatocarcinogenesis in rats fed a choline-devoid diet. Carcinogenesis (1986) 1.00
Quantitation of estrogen and androgen receptors in hepatocellular carcinoma and adjacent normal human liver. Dig Dis Sci (1991) 1.00
Biopsy diagnosis of well-differentiated hepatocellular carcinoma based on new morphologic criteria. Hepatology (1989) 1.00
Hepatocellular and gastric carcinoma associated with familial polyposis coli. J Surg Oncol (1988) 0.96
Clonal origin of human hepatoma determined by integration of hepatitis B virus DNA. Cancer Res (1986) 0.96
Time trends of primary liver cancer: indication of increased incidence in selected cancer registry populations. J Natl Cancer Inst (1980) 0.96
The epidemiology and natural history of HIV/HBV and HIV/HCV co-infections. J HIV Ther (2003) 0.95
Drinking water and liver cell cancer: an epidemiologic approach to the etiology of this disease in China. Chin Med J (Engl) (1979) 0.93
Hepatocellular carcinoma and African iron overload. Gut (1995) 0.91
Macroregenerative (dysplastic) nodules and hepatocarcinogenesis: theoretical and clinical considerations. Semin Liver Dis (1995) 0.91
Hereditary tyrosinemia type I (chronic form): pathologic findings in the liver. Hum Pathol (1989) 0.89
Clustering of hepatocellular carcinoma in Alaska Native families. Genet Epidemiol (1991) 0.89
Hepatocellular carcinoma in children. Pediatr Surg Int (1997) 0.89
Acute hepatic porphyria and hepatocellular carcinoma. Br J Cancer (1988) 0.88
The male preponderance in incidence of hepatocellular carcinoma in cirrhotic patients may depend on the higher DNA synthetic activity of cirrhotic tissue in men. Cancer (1993) 0.87
Hepatocellular carcinoma. Gastroenterologist (1995) 0.87
Geographic variations in Wilson's disease. J Neurol Sci (1993) 0.87
[Hepatocellular carcinoma in Germany. Epidemiology, etiology, clinical aspects and prognosis in 100 consecutive patients of a university clinic]. Z Gastroenterol (1997) 0.84
Childhood primary hepatocellular carcinoma and hepatitis B virus infection. Cancer (1990) 0.84
Ataxia telangiectasia with hepatocellular carcinoma in a 15-year-old girl and studies of her kindred. Arch Pathol Lab Med (1985) 0.83
Rising incidence of hepatocellular carcinoma: the role of hepatitis B and C; the impact on transplantation and outcomes. Clin Liver Dis (2003) 0.82
Karyometric analysis of liver cell dysplasia and hepatocellular carcinoma. Evidence against precancerous nature of liver cell dysplasia. Cancer (1985) 0.82
[Changes of clinical aspect of primary liver cancer in China during the past 30 years--control study for 3,250 cases with primary liver cancer]. Zhonghua Yi Xue Za Zhi (2003) 0.82
Progression of hepatitis B and C to hepatocellular carcinoma in Western countries. Hepatogastroenterology (1998) 0.82
Hepatocellular carcinoma and hepatic cirrhosis in Mexico: a 25 year necroscopy review. Hepatogastroenterology (1997) 0.81
The association of hepatocellular carcinoma in childhood with hepatitis B virus infection. Cancer (1988) 0.81
Hepatitis B virus gene in liver tissue promotes hepatocellular carcinoma development in chronic hepatitis C patients. Dig Dis Sci (2003) 0.81
Alcohol and other chemicals in the development of hepatocellular carcinoma. Clin Lab Med (1996) 0.81
Nodular transformation of the liver, alpha-fetoprotein, and hepatocellular carcinoma. Hum Pathol (1981) 0.81
Recent studies on the developing human hepatocellular carcinoma. Cancer Surv (1986) 0.80
Hepatocellular carcinoma and hepatitis B virus infection: molecular evidence for monoclonal origin and expansion of malignantly transformed hepatocytes. J Cancer Res Clin Oncol (1987) 0.79
Liver cell dysplasia: a DNA aneuploid lesion with distinct morphologic features. Hum Pathol (1992) 0.79
Characterisation of the DNA repair enzyme for O(6)-methylguanine in cirrhosis. J Hepatol (1996) 0.79
Hepatocellular carcinoma associated with congenital macronodular cirrhosis in a neonate. J Pediatr Surg (1986) 0.79
Abnormal DNA content in liver-cell dysplasia: a flow cytometric study. Int J Cancer (1989) 0.78
Morphological clues for the diagnosis of small hepatocellular carcinomas. Virchows Arch A Pathol Anat Histopathol (1987) 0.78
Hormonal manipulation of human hepatocellular carcinoma. A clinical investigative and therapeutic opportunity. J Hepatol (1990) 0.77
Specificity of androgen receptors of hepatocellular carcinoma and liver in humans. Hepatogastroenterology (1990) 0.77
Clonal origin of hepatitis B virus-associated hepatocellular carcinoma. Hum Pathol (1988) 0.77
Hepatocellular carcinoma, alcohol, and cirrhosis: facts and hypotheses. Dig Dis Sci (1991) 0.77
Liver cell atypias: a comparative study in cirrhosis with and without hepatocellular carcinoma. Histopathology (1997) 0.76
Treatment of primary liver cancer in Singapore. A review of 3200 cases seen between January 1, 1977, and July 31, 1987. Cancer Chemother Pharmacol (1989) 0.76
S-adenosylmethionine, S-adenosylhomocysteine and DNA methylation levels in the liver of rats fed methapyrilene and analogs. Carcinogenesis (1989) 0.76
Incidence and epidemiological factors of hepatocellular carcinoma in Valencia during the year 2000. Rev Esp Enferm Dig (2003) 0.76
Tumor genes and their proteins in cytologic and surgical specimens: relevance and detection systems. Diagn Cytopathol (1995) 0.76
Multiple organ infection and the pathogenesis of SARS. J Exp Med (2005) 1.58
Prognostic relevance of immunohistochemically detected lymph node micrometastasis in patients with gastric carcinoma. Cancer (2002) 1.27
Controversies in the assessment of HER-2: more questions than answers. Adv Anat Pathol (2006) 1.10
The morphological spectrum of lymphadenopathy in HIV infected patients. Pathology (2007) 1.06
Ultra-rapid microwave-stimulated tissue processing with a modified protocol incorporating microwave fixation. Pathology (2004) 1.05
Immunohistology--past, present, and future. Adv Anat Pathol (2010) 0.97
The role of molecular studies in lymphoma diagnosis: a review. Pathology (2004) 0.89
p16, cyclin D1, Ki-67, and AMACR as markers for dysplasia in Barrett esophagus. Appl Immunohistochem Mol Morphol (2008) 0.85
How does antigen retrieval work? Adv Anat Pathol (2007) 0.85
Immunohistological localisation of human FAT1 (hFAT) protein in 326 breast cancers. Does this adhesion molecule have a role in pathogenesis? Pathology (2006) 0.84
Digital imaging applications in anatomic pathology. Adv Anat Pathol (2003) 0.82
Cytokeratin 20 and Ki-67 to distinguish carcinoma in situ from flat non-neoplastic urothelium. Appl Immunohistochem Mol Morphol (2006) 0.81
Occurrence of c-kit+ tumor cells in hepatitis B virus-associated hepatocellular carcinoma. Am J Clin Pathol (2005) 0.81
Practical telepathology using a digital camera and the internet. Telemed J E Health (2002) 0.78
Basal lamina visualization using color image processing and pattern recognition. Appl Immunohistochem Mol Morphol (2005) 0.78
Diagnostic pathology of lymphoproliferative disorders. Pathology (2005) 0.77
CDX2 and villin are useful markers of intestinal metaplasia in the diagnosis of Barrett esophagus. Am J Clin Pathol (2008) 0.77
Quantitative immunohistology: tissue section thickness, another glitch in the path to standardization. Appl Immunohistochem Mol Morphol (2009) 0.77
Calretinin, CD34, and alpha-smooth muscle actin in the identification of peritoneal invasive implants of serous borderline tumors of the ovary. Mod Pathol (2006) 0.76
Objectivity in image analysis. Pathology (2010) 0.75
Glomeruloid peritoneal implants in ovarian serous borderline tumours--distinction between invasive and non-invasive implants and pathogenesis. Histopathology (2009) 0.75